top of page

RECENT NEWS

NFL Biosciences successful IPO on Euronext Growth Paris
June 30, 2021​

click here to download the press release

NFL Biosciences launches IPO on Euronext Growth Paris
June 16, 2021​

>> click here to access dedicated website (in French only)

A French innovation for smoking cessation approved for a Phase II clinical study
June 2, 2021

 

  • A novel botanical approach to smoking cessation to be tested on 318 smokers

  • A Phase II clinical trial approved by the Human Research Ethics Committee (HREC) in Australia to avoid the effects of the health crisis in Europe

>> click here (or the image) to download the press release in French
bottom of page